How Lowering The Price of a Common Asthma Drug Made it Harder to Get
Wall Street Journal
To avoid Medicaid penalties, Glaxo and other drugmakers lowered prices. For popular asthma drug Flovent HFA, the tactic to replace it with a generic backfired.
Understanding current events through the lenses of the past and future.
Wall Street Journal
To avoid Medicaid penalties, Glaxo and other drugmakers lowered prices. For popular asthma drug Flovent HFA, the tactic to replace it with a generic backfired.